Concepts (236)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thyroid Hormones | 10 | 2019 | 56 | 1.910 |
Why?
|
| Nuclear Receptor Co-Repressor 1 | 11 | 2019 | 51 | 1.520 |
Why?
|
| Receptors, Thyroid Hormone | 8 | 2015 | 46 | 1.370 |
Why?
|
| Liver | 12 | 2025 | 1797 | 0.990 |
Why?
|
| Co-Repressor Proteins | 3 | 2015 | 38 | 0.960 |
Why?
|
| Nuclear Proteins | 6 | 2017 | 1280 | 0.670 |
Why?
|
| Thyroid Gland | 4 | 2015 | 104 | 0.640 |
Why?
|
| Thyroid Hormone Receptors beta | 5 | 2017 | 17 | 0.640 |
Why?
|
| Triiodothyronine | 5 | 2014 | 59 | 0.590 |
Why?
|
| Hypothyroidism | 4 | 2017 | 78 | 0.580 |
Why?
|
| Energy Metabolism | 4 | 2025 | 785 | 0.540 |
Why?
|
| Repressor Proteins | 4 | 2009 | 812 | 0.510 |
Why?
|
| Gene Expression Regulation | 8 | 2021 | 2438 | 0.500 |
Why?
|
| Cholesterol | 4 | 2019 | 558 | 0.470 |
Why?
|
| Hypothalamo-Hypophyseal System | 2 | 2015 | 68 | 0.450 |
Why?
|
| Sulfotransferases | 3 | 2004 | 25 | 0.440 |
Why?
|
| Fructose | 3 | 2021 | 62 | 0.440 |
Why?
|
| Thyroid Hormone Resistance Syndrome | 3 | 2019 | 6 | 0.350 |
Why?
|
| Transcription, Genetic | 2 | 2015 | 1422 | 0.350 |
Why?
|
| Lipid Metabolism | 3 | 2025 | 381 | 0.320 |
Why?
|
| Animals | 31 | 2025 | 34882 | 0.300 |
Why?
|
| Nuclear Receptor Co-Repressor 2 | 3 | 2019 | 33 | 0.280 |
Why?
|
| Hepatocytes | 2 | 2008 | 237 | 0.270 |
Why?
|
| Mice, Knockout | 9 | 2025 | 3863 | 0.260 |
Why?
|
| Thyroxine | 4 | 2019 | 65 | 0.260 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 3 | 2025 | 193 | 0.260 |
Why?
|
| Promoter Regions, Genetic | 5 | 2025 | 1280 | 0.250 |
Why?
|
| Thyrotropin | 4 | 2019 | 56 | 0.250 |
Why?
|
| Protein Binding | 6 | 2015 | 1729 | 0.230 |
Why?
|
| Mice | 19 | 2025 | 18507 | 0.220 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2025 | 291 | 0.210 |
Why?
|
| Transcription Factors | 4 | 2025 | 2493 | 0.200 |
Why?
|
| Succinic Acid | 1 | 2022 | 13 | 0.190 |
Why?
|
| Circadian Rhythm | 1 | 2025 | 317 | 0.190 |
Why?
|
| 5' Untranslated Regions | 1 | 2002 | 57 | 0.190 |
Why?
|
| Liver X Receptors | 2 | 2014 | 17 | 0.180 |
Why?
|
| Orphan Nuclear Receptors | 2 | 2014 | 21 | 0.180 |
Why?
|
| Systems Analysis | 1 | 2021 | 16 | 0.180 |
Why?
|
| Triglycerides | 2 | 2021 | 617 | 0.180 |
Why?
|
| Hyperinsulinism | 1 | 2021 | 62 | 0.180 |
Why?
|
| Introns | 1 | 2002 | 305 | 0.170 |
Why?
|
| Lipogenesis | 2 | 2018 | 60 | 0.170 |
Why?
|
| Metabolomics | 1 | 2025 | 480 | 0.170 |
Why?
|
| Fibroblast Growth Factors | 2 | 2014 | 166 | 0.170 |
Why?
|
| Hypertriglyceridemia | 1 | 2021 | 114 | 0.160 |
Why?
|
| Sodium-Glucose Transporter 2 | 1 | 2020 | 18 | 0.160 |
Why?
|
| Food Deprivation | 1 | 2020 | 34 | 0.160 |
Why?
|
| Glucagon | 1 | 2020 | 151 | 0.160 |
Why?
|
| Glucosides | 1 | 2020 | 48 | 0.160 |
Why?
|
| Exons | 1 | 2002 | 805 | 0.160 |
Why?
|
| Thyroid Hormone Receptors alpha | 1 | 2019 | 10 | 0.150 |
Why?
|
| Benzhydryl Compounds | 1 | 2020 | 68 | 0.150 |
Why?
|
| Signal Transduction | 6 | 2017 | 4703 | 0.150 |
Why?
|
| 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) | 1 | 2018 | 9 | 0.140 |
Why?
|
| ATP Citrate (pro-S)-Lyase | 1 | 2018 | 8 | 0.140 |
Why?
|
| Fructose-Bisphosphate Aldolase | 1 | 2018 | 8 | 0.140 |
Why?
|
| Insulin | 2 | 2021 | 1168 | 0.140 |
Why?
|
| Mutation | 5 | 2017 | 6229 | 0.140 |
Why?
|
| Glucose | 1 | 2023 | 878 | 0.140 |
Why?
|
| Fructose Intolerance | 1 | 2017 | 3 | 0.140 |
Why?
|
| Transcriptome | 1 | 2025 | 1125 | 0.140 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2018 | 75 | 0.140 |
Why?
|
| Gene Expression Profiling | 1 | 2025 | 1882 | 0.140 |
Why?
|
| Rats | 6 | 2025 | 3611 | 0.130 |
Why?
|
| Mice, Inbred C57BL | 7 | 2025 | 4757 | 0.130 |
Why?
|
| Molecular Sequence Data | 3 | 2009 | 3770 | 0.120 |
Why?
|
| Pituitary Gland | 2 | 2014 | 81 | 0.120 |
Why?
|
| Blotting, Western | 3 | 2019 | 1077 | 0.120 |
Why?
|
| Nuclear Receptor Coactivator 1 | 2 | 2014 | 162 | 0.120 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2015 | 143 | 0.120 |
Why?
|
| Gene Expression | 2 | 2011 | 1558 | 0.110 |
Why?
|
| Body Weight | 1 | 2019 | 994 | 0.110 |
Why?
|
| Histone Deacetylases | 1 | 2015 | 122 | 0.110 |
Why?
|
| Pluripotent Stem Cells | 1 | 2015 | 75 | 0.110 |
Why?
|
| Organ Specificity | 1 | 2015 | 412 | 0.110 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2022 | 811 | 0.110 |
Why?
|
| Multiprotein Complexes | 1 | 2015 | 201 | 0.110 |
Why?
|
| Structure-Activity Relationship | 1 | 2015 | 588 | 0.110 |
Why?
|
| Lipotropic Agents | 1 | 2014 | 6 | 0.110 |
Why?
|
| Cholestanetriol 26-Monooxygenase | 1 | 2014 | 15 | 0.110 |
Why?
|
| RNA, Messenger | 5 | 2021 | 2674 | 0.110 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2014 | 50 | 0.110 |
Why?
|
| Models, Animal | 1 | 2015 | 470 | 0.100 |
Why?
|
| Polymerase Chain Reaction | 2 | 2011 | 1548 | 0.100 |
Why?
|
| Lipids | 4 | 2023 | 561 | 0.100 |
Why?
|
| Tumor Microenvironment | 1 | 2018 | 688 | 0.100 |
Why?
|
| Protein Structure, Tertiary | 3 | 2011 | 764 | 0.100 |
Why?
|
| Regeneration | 1 | 2015 | 226 | 0.100 |
Why?
|
| Forkhead Transcription Factors | 1 | 2015 | 381 | 0.100 |
Why?
|
| Ligands | 2 | 2012 | 494 | 0.100 |
Why?
|
| Nuclear Receptor Coactivator 2 | 1 | 2014 | 148 | 0.100 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2015 | 445 | 0.100 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2014 | 197 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 500 | 0.100 |
Why?
|
| Retinoid X Receptors | 2 | 2010 | 25 | 0.100 |
Why?
|
| Intestinal Mucosa | 1 | 2017 | 794 | 0.100 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 2003 | 261 | 0.100 |
Why?
|
| Dietary Fats | 1 | 2014 | 279 | 0.100 |
Why?
|
| Chromatin | 1 | 2015 | 518 | 0.090 |
Why?
|
| Cell Line | 4 | 2015 | 2719 | 0.090 |
Why?
|
| Mice, Mutant Strains | 2 | 2011 | 378 | 0.090 |
Why?
|
| Colorectal Neoplasms | 1 | 2018 | 632 | 0.090 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2014 | 323 | 0.090 |
Why?
|
| Cells, Cultured | 3 | 2017 | 3036 | 0.080 |
Why?
|
| Mutant Proteins | 1 | 2011 | 116 | 0.080 |
Why?
|
| Male | 16 | 2025 | 64922 | 0.080 |
Why?
|
| Carrier Proteins | 1 | 2015 | 1047 | 0.080 |
Why?
|
| In Situ Hybridization | 1 | 2011 | 468 | 0.080 |
Why?
|
| Androgen Receptor Antagonists | 2 | 2007 | 41 | 0.080 |
Why?
|
| PPAR alpha | 1 | 2010 | 53 | 0.080 |
Why?
|
| DNA-Binding Proteins | 2 | 2008 | 1977 | 0.080 |
Why?
|
| Cell Differentiation | 2 | 2015 | 1960 | 0.080 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2009 | 66 | 0.080 |
Why?
|
| Base Sequence | 2 | 2003 | 2899 | 0.070 |
Why?
|
| Conserved Sequence | 1 | 2009 | 296 | 0.070 |
Why?
|
| Genome-Wide Association Study | 1 | 2015 | 1828 | 0.070 |
Why?
|
| Species Specificity | 1 | 2009 | 541 | 0.070 |
Why?
|
| Tosyl Compounds | 1 | 2007 | 24 | 0.070 |
Why?
|
| Humans | 14 | 2025 | 132062 | 0.070 |
Why?
|
| Liver Neoplasms | 1 | 2018 | 1381 | 0.070 |
Why?
|
| Anilides | 1 | 2007 | 58 | 0.070 |
Why?
|
| Nitriles | 1 | 2007 | 154 | 0.060 |
Why?
|
| Binding, Competitive | 2 | 2004 | 161 | 0.060 |
Why?
|
| Obesity | 1 | 2018 | 2391 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2014 | 1610 | 0.060 |
Why?
|
| Acetylation | 2 | 2017 | 191 | 0.060 |
Why?
|
| Receptors, Calcitriol | 1 | 2006 | 61 | 0.060 |
Why?
|
| Receptors, Androgen | 2 | 2007 | 409 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 1044 | 0.060 |
Why?
|
| Coenzyme A | 1 | 2025 | 6 | 0.060 |
Why?
|
| Hormone Antagonists | 1 | 2004 | 49 | 0.060 |
Why?
|
| Mifepristone | 1 | 2004 | 99 | 0.060 |
Why?
|
| Adipocytes | 1 | 2006 | 178 | 0.060 |
Why?
|
| Amino Acid Sequence | 1 | 2009 | 2669 | 0.060 |
Why?
|
| 5' Flanking Region | 1 | 2004 | 10 | 0.060 |
Why?
|
| Nuclear Matrix | 1 | 2004 | 20 | 0.050 |
Why?
|
| Circadian Clocks | 1 | 2025 | 82 | 0.050 |
Why?
|
| Binding Sites | 2 | 2004 | 1256 | 0.050 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2003 | 54 | 0.050 |
Why?
|
| Succinates | 1 | 2022 | 19 | 0.050 |
Why?
|
| Oligonucleotides | 1 | 2003 | 97 | 0.050 |
Why?
|
| Sex Factors | 2 | 2004 | 1353 | 0.050 |
Why?
|
| Transcription Initiation Site | 1 | 2002 | 33 | 0.050 |
Why?
|
| Citric Acid Cycle | 1 | 2022 | 46 | 0.050 |
Why?
|
| Receptors, Estrogen | 1 | 2025 | 728 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 3014 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2025 | 1222 | 0.050 |
Why?
|
| Mice, Inbred C3H | 1 | 2021 | 118 | 0.050 |
Why?
|
| Cloning, Molecular | 1 | 2002 | 811 | 0.040 |
Why?
|
| Female | 9 | 2025 | 70712 | 0.040 |
Why?
|
| Gene Duplication | 1 | 2002 | 369 | 0.040 |
Why?
|
| Haplotypes | 1 | 2021 | 544 | 0.040 |
Why?
|
| Alternative Splicing | 1 | 2002 | 363 | 0.040 |
Why?
|
| Lipolysis | 1 | 2020 | 75 | 0.040 |
Why?
|
| Calcification, Physiologic | 1 | 2019 | 24 | 0.040 |
Why?
|
| Gene Regulatory Networks | 1 | 2021 | 385 | 0.040 |
Why?
|
| Epinephrine | 1 | 2020 | 155 | 0.040 |
Why?
|
| Bone Development | 1 | 2019 | 55 | 0.040 |
Why?
|
| Cell Nucleus | 2 | 2015 | 587 | 0.040 |
Why?
|
| Receptors, Somatotropin | 1 | 1998 | 9 | 0.040 |
Why?
|
| Glucose Tolerance Test | 1 | 2019 | 207 | 0.040 |
Why?
|
| Homeostasis | 1 | 2023 | 721 | 0.040 |
Why?
|
| Rats, Zucker | 1 | 2018 | 24 | 0.040 |
Why?
|
| Prostatic Neoplasms | 1 | 2007 | 1539 | 0.040 |
Why?
|
| Intestines | 1 | 2022 | 603 | 0.040 |
Why?
|
| HCT116 Cells | 1 | 2018 | 60 | 0.040 |
Why?
|
| Glucose Transporter Type 5 | 1 | 2017 | 5 | 0.040 |
Why?
|
| Mice, Transgenic | 2 | 2015 | 2445 | 0.030 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2017 | 22 | 0.030 |
Why?
|
| Protein Phosphatase 2C | 1 | 2018 | 60 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2018 | 314 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2018 | 329 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2019 | 540 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2021 | 935 | 0.030 |
Why?
|
| Weight Gain | 1 | 2019 | 381 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 1998 | 327 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2025 | 2849 | 0.030 |
Why?
|
| Bone Density | 1 | 2019 | 367 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2002 | 1799 | 0.030 |
Why?
|
| Rapamycin-Insensitive Companion of mTOR Protein | 1 | 2015 | 6 | 0.030 |
Why?
|
| Xenopus | 1 | 2015 | 103 | 0.030 |
Why?
|
| Mechanistic Target of Rapamycin Complex 2 | 1 | 2015 | 30 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2018 | 799 | 0.030 |
Why?
|
| Hep G2 Cells | 1 | 2015 | 94 | 0.030 |
Why?
|
| NAD | 1 | 2015 | 52 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2018 | 1046 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2017 | 677 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2020 | 1123 | 0.030 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2015 | 97 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2018 | 719 | 0.030 |
Why?
|
| Sirtuin 1 | 1 | 2015 | 54 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2015 | 236 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2018 | 4688 | 0.030 |
Why?
|
| Protein Transport | 1 | 2015 | 369 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2015 | 615 | 0.030 |
Why?
|
| Hyperthyroidism | 1 | 2014 | 24 | 0.030 |
Why?
|
| Weight Loss | 1 | 2017 | 515 | 0.030 |
Why?
|
| Histones | 1 | 2017 | 534 | 0.030 |
Why?
|
| Echocardiography | 1 | 2019 | 1129 | 0.030 |
Why?
|
| Adipose Tissue, Brown | 1 | 2014 | 87 | 0.030 |
Why?
|
| Transfection | 2 | 2006 | 996 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2015 | 876 | 0.020 |
Why?
|
| Thyrotropin-Releasing Hormone | 1 | 2012 | 9 | 0.020 |
Why?
|
| Hyperlipidemias | 1 | 2014 | 188 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2021 | 5164 | 0.020 |
Why?
|
| Genes, erbA | 1 | 2011 | 1 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2015 | 1608 | 0.020 |
Why?
|
| Phenotype | 1 | 2021 | 4529 | 0.020 |
Why?
|
| Hormone Replacement Therapy | 1 | 2014 | 211 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2014 | 792 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2014 | 1347 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2011 | 526 | 0.020 |
Why?
|
| Adipose Tissue, White | 1 | 2010 | 94 | 0.020 |
Why?
|
| Cricetulus | 1 | 2007 | 93 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2014 | 1033 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 1284 | 0.020 |
Why?
|
| Cricetinae | 1 | 2007 | 381 | 0.020 |
Why?
|
| Histone Acetyltransferases | 1 | 2007 | 227 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 7102 | 0.020 |
Why?
|
| 3T3-L1 Cells | 1 | 2006 | 57 | 0.020 |
Why?
|
| Calcitriol | 1 | 2006 | 65 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2007 | 1045 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 2006 | 234 | 0.010 |
Why?
|
| Androgens | 1 | 2007 | 277 | 0.010 |
Why?
|
| Dihydrotestosterone | 1 | 2004 | 72 | 0.010 |
Why?
|
| RNA Interference | 1 | 2006 | 514 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2006 | 687 | 0.010 |
Why?
|
| Kidney | 1 | 2010 | 1331 | 0.010 |
Why?
|
| Models, Biological | 1 | 2007 | 1443 | 0.010 |
Why?
|
| Adolescent | 1 | 2018 | 20562 | 0.010 |
Why?
|
| Aged | 1 | 2018 | 21406 | 0.010 |
Why?
|
| Middle Aged | 1 | 2018 | 28964 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2007 | 1824 | 0.010 |
Why?
|
| Adult | 1 | 2018 | 31568 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2004 | 3681 | 0.010 |
Why?
|
| Time Factors | 1 | 2006 | 6448 | 0.010 |
Why?
|